Differential regulation of apolipoprotein-E messenger RNA in zona fasciculata cells of rat adrenal gland determined by in situ hybridization.
Previous studies showed that apolipoprotein-E (apoE) mRNA is regulated in rat adrenal gland by treatments that alter adrenal gland cholesterol content and steroidogenesis. In the present study cell types expressing apoE mRNA were determined by in situ hybridizations using an [alpha-35S]UTP-labeled RNA probe. Autoradiographic grains were counted to compare apoE expression in adrenal glands from control and experimentally treated animals. In control adrenal gland, zona (z.) fasciculata and z. reticularis exhibited the highest level of apoE mRNA expression, with lower levels in z. glomerulosa and medulla. Dexamethasone (DEX) treatment selectively increased apoE mRNA 3-fold in outer z. fasciculata, but not in other adrenal zones. ApoE mRNA expression appeared to be lower in adrenal glands from 4-aminopyrazolopyrimidine-treated rats, in that differences among adrenal gland zones were abolished. DEX treatment increased adrenal gland cholesteryl ester and oil red O staining in z. fasciculata cells in which the apoE mRNA concentration was increased as well as in other cortical cells in which apoE mRNA was unchanged. Aminoglutethimide administration led to a large increase in oil red O staining throughout the cortex, including z. fasciculata, without affecting apoE mRNA expression. These data suggest that adrenal gland apoE mRNA expression is not closely coupled to cellular cholesterol concentrations. Increased apoE mRNA expression in z. fasciculata of DEX-treated animals suggests an inverse relationship between apoE mRNA concentration and the level of steroidogenesis. This result is consistent with the proposal that apoE may play a role in regulating the utilization of cholesterol for steroid production.
Nicosia
M
M
Department of Pharmacological Sciences, State University of New York, Stony Brook 11794.
Prack
M M
MM
Williams
D L
DL
D000311:Adrenal Glands / Q000737:chemistry / Q000166:cytology / Q000378:metabolism; D000616:Aminoglutethimide / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001057:Apolipoproteins E / Q000096:biosynthesis / Q000235:genetics*; D001391:Azo Compounds; D002788:Cholesterol Esters / Q000032:analysis; D003907:Dexamethasone / Q000494:pharmacology; D005786:Gene Expression Regulation; D008055:Lipids / Q000032:analysis; D008297:Male; D009693:Nucleic Acid Hybridization; D015347:RNA Probes; D012333:RNA, Messenger / Q000235:genetics* / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013194:Staining and Labeling; D015383:Zona Fasciculata / Q000737:chemistry / Q000166:cytology / Q000378:metabolism*
D001057:Apolipoproteins E; D001391:Azo Compounds; D002788:Cholesterol Esters; D008055:Lipids; D015347:RNA Probes; D012333:RNA, Messenger; D000616:Aminoglutethimide; D003907:Dexamethasone; C011049:oil red O